BELGIUM, an integrated value chain for radiation applications in healthcare

Key facts and figures…

Belgium is one of the major worldwide actors to produce medical isotopes, radiopharmaceuticals, and nuclear medical equipment including cameras and cyclotrons:

Major producer of radioisotopes
  • Second supplier of 99Mo worldwide
  • BR2 reactor of SCK
  • CEN is one of the 5 most powerful research reactors in the world
  • IRE is one of the 5 centres in the world able to process 99Mo
High density of nuclear medical equipment
  • IBA is a global leader in proton therapy, radiopharma solutions and dosimetry
  • 26 PET cameras: ratio 2.4 PET camera per million inhabitants
  • 10 cyclotrons (mainly, but not exclusively to produce 18FDG)
High density of nuclear physicists and nuclear physicians
  • 11 different training centres (for technicians, radiologists and nuclear physicians)
  • +/- 300 nuclear physicians: 27 per million inhabitants
Employment and major investments in the field
  • 2 600 direct jobs and 2 100 indirect jobs
  • International MYRRHA project: > €1000M over 20 years

Belgium, a country at the very heart of Europe

Location and Logistics are key factors for success in the field of radiation applications in Healthcare.
Belgium, ideally located between Northern and Southern Europe is neighbour to France, Germany, Luxembourg and the Netherlands. Its small size – around 30,000 km2 – allows for rapid internal communication thanks to its efficient motorway system. The 5 airports (including the Brussels international airport – the ideal hub for isotope transport) put the region less than two hours from most European destinations. The high-speed train lines spanning the country with 3,000 km of electrified tracks also places its major cities (Antwerp, Brussels, Charleroi, Ghent, Liège and Namur) within a 2-hour proximity to Paris, London, Amsterdam or Frankfurt.